These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34583803)

  • 1. MicroRNAs regulating SOX2 in cancer progression and therapy response.
    Mirzaei S; Saebfar H; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Entezari M; Hushmandi K; Samarghandian S; Aref AR; Ashrafizadeh M; Khan H
    Expert Rev Mol Med; 2021 Sep; 23():e13. PubMed ID: 34583803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
    Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
    Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between SOX9 transcription factor and microRNAs in cancer.
    Ashrafizadeh M; Zarrabi A; Orouei S; Zabolian A; Saleki H; Azami N; Bejandi AK; Mirzaei S; Janaghard MN; Hushmandi K; Nabavi N; Baradaran B; Kumar AP; Makvandi P; Samarghandian S; Khan H; Hamblin MR
    Int J Biol Macromol; 2021 Jul; 183():681-694. PubMed ID: 33957202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
    Mirzaei S; Paskeh MDA; Entezari M; Mirmazloomi SR; Hassanpoor A; Aboutalebi M; Rezaei S; Hejazi ES; Kakavand A; Heidari H; Salimimoghadam S; Taheriazam A; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Dec; 156():113860. PubMed ID: 36272267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA ES1 controls the proliferation of breast cancer cells by regulating the Oct4/Sox2/miR-302 axis.
    Keshavarz M; Asadi MH
    FEBS J; 2019 Jul; 286(13):2611-2623. PubMed ID: 30927330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.
    Wo Q; Zhang D; Hu L; Lyu J; Xiang F; Zheng W; Shou J; Qi X
    Biochem Biophys Res Commun; 2019 Dec; 520(3):586-593. PubMed ID: 31623830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
    Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy.
    Huang P; Wen F; Li Y; Li Q
    Life Sci; 2024 May; 344():122576. PubMed ID: 38492918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response.
    Hashemi M; Rashidi M; Hushmandi K; Ten Hagen TLM; Salimimoghadam S; Taheriazam A; Entezari M; Falahati M
    Pharmacol Res; 2023 Apr; 190():106732. PubMed ID: 36931542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis.
    Ashrafizadeh M; Gholami MH; Mirzaei S; Zabolian A; Haddadi A; Farahani MV; Kashani SH; Hushmandi K; Najafi M; Zarrabi A; Ahn KS; Khan H
    Life Sci; 2021 Apr; 270():119006. PubMed ID: 33421521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.
    Otsubo T; Akiyama Y; Hashimoto Y; Shimada S; Goto K; Yuasa Y
    PLoS One; 2011 Jan; 6(1):e16617. PubMed ID: 21304604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
    Mirzaei S; Zarrabi A; Asnaf SE; Hashemi F; Zabolian A; Hushmandi K; Raei M; Goharrizi MASB; Makvandi P; Samarghandian S; Najafi M; Ashrafizadeh M; Aref AR; Hamblin MR
    Life Sci; 2021 Mar; 268():119005. PubMed ID: 33421526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2-associated signaling pathways regulate biological phenotypes of cancers.
    Ding LN; Yu YY; Ma CJ; Lei CJ; Zhang HB
    Biomed Pharmacother; 2023 Apr; 160():114336. PubMed ID: 36738502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
    Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
    Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
    Zhang H; Xu W
    Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
    Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
    J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2.
    Zhang C; Xie L; Fu Y; Yang J; Cui Y
    J Cell Physiol; 2020 Nov; 235(11):7933-7944. PubMed ID: 31943174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 20. Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis.
    Gao Z; Wang Q; Ji M; Guo X; Li L; Su X
    J Transl Med; 2021 May; 19(1):229. PubMed ID: 34053467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.